Skip to content

Olive (Olea europaea) leaf extract on blood pressure

The effects of olive (Olea europaea) leaf extract on blood pressure and oxidative stress parameters and lipid profiles in patients with hypertension

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017043033730N1
Enrollment
60
Registered
2017-05-31
Start date
2017-05-08
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential hypertension. Hypertensive diseases

Interventions

Intervention 1: The intervention group: olive leaf extract as 250 mg tablet, orally ,twice a day for 12 weeks. Intervention 2: The control group: Cellulose as 250 mg tablet as placebo, orally twice a
Treatment - Drugs
Placebo
The intervention group: olive leaf extract as 250 mg tablet, orally ,twice a day for 12 weeks.
The control group: Cellulose as 250 mg tablet as placebo, orally twice a day for 12 weeks.

Sponsors

Vice Chancellor for research of Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: subjects with systolic blood pressure (SBP) above 140 mmHg or diastolic blood pressure (DBP) above 90 mmHg. Exclusion criteria: patients who do not want to cooperate; hypertensive patients who have others complications such as: kidney disease? neuropathy and retinopathy; patients with hypo and/or hyperthyroidism are excluded from this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood Pressure. Timepoint: Before and after intervention. Method of measurement: based on mmHg using sphigmomanometer.;MDA. Timepoint: Before and after intervention. Method of measurement: Elisa.;Total antioxidant capacity. Timepoint: Before and after intervention. Method of measurement: spectrophotometeric.;Lipid profiles. Timepoint: Before and after intervention. Method of measurement: spectrophotometeric.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Seyyed Mehdi Mirhashemi

Qazvin University of Medical Sciences

mirhashemism@gmail.com; sm.mirhashemi@qums.ac.ir+98 28 3333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026